PMC Links for Books (Select 4859744) - PMC

Result Filters

Links from Books

Items: 1 to 20 of 41

<< First< Prev

Page of 3

Select item 98316711.

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Gail V Matthews, Sanjay Bhagani, Marc Van der Valk, Juergen Rockstroh, Jordan J Feld, Andri Rauch, Christine Thurnheer, Julie Bruneau, Arthur Kim, Margaret Hellard, David Shaw, Ed Gane, Mark Nelson, Patrick Ingiliz, Tanya L Applegate, Jason Grebely, Phillipa Marks, Marianne Martinello, Kathy Petoumenos, Gregory J Dore, REACT study group

J Hepatol. Author manuscript; available in PMC 2023 Jan 10.

Published in final edited form as: J Hepatol. 2021 Oct; 75(4): 829–839. Published online 2021 May 21. doi: 10.1016/j.jhep.2021.04.056

PMCID:: PMC9831671

Abstract Article PDF–1.3M

Select item 88474922.

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

Pin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, Chi-Yi Chen, Chung-Feng Huang, Hsing-Tao Kuo, Ching-Chu Lo, Kuo-Chih Tseng, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Chun-Yen Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Te Sheng Chang, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Kwok-Hsiung Chou, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chien-Yu Cheng, Ming-Chang Tsai, Chun-Jen Liu, Chia-Yen Dai, Han-Chieh Lin, Jia-Horng Kao, Wan-Long Chuang, Ming-Lung Yu, TACR investigators

Infect Dis Ther. 2022 Feb; 11(1): 485–500. Published online 2021 Dec 28. doi: 10.1007/s40121-021-00576-7

PMCID:: PMC8847492

Abstract Article PDF–672K

Select item 80966393.

Retrospective-Prospective Study of Safety and Efficacy of Sofosbuvir based Direct Acting Antivirals in HIV/HCV Coinfected Participants with Decompensated Liver Disease Pre or Post Liver Transplant

Marion G. Peters, Shyam Kottilil, Norah Terrault, Dominic Amara, Jennifer Husson, Shirish Huprikar, Sander Florman, Mark S. Sulkowski, Christine M. Durand, Anne F. Luetkemeyer, Rodney Rogers, Joshua Grab, Brandy Haydel, Emily Blumberg, Lorna Dove, Jean Emond, Kim Olthoff, Coleman Smith, Thomas Fishbein, Henry Masur, Peter G. Stock

Am J Transplant. Author manuscript; available in PMC 2022 May 1.

Published in final edited form as: Am J Transplant. 2021 May; 21(5): 1780–1788. Published online 2020 Dec 23. doi: 10.1111/ajt.16427

PMCID:: PMC8096639

Abstract Article PDF–577K

Select item 78202144.

Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study

Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han

Clin Mol Hepatol. 2021 Jan; 27(1): 125–135. Published online 2020 Nov 27. doi: 10.3350/cmh.2020.0023

PMCID:: PMC7820214

Abstract Article PDF–640K

Select item 76804815.

Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study

Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Makoto Nakamuta, Koichi Takaguchi, Tsunamasa Watanabe, Atsushi Hiraoka, Haruki Uojima, Toru Ishikawa, Motoh Iwasa, Toshifumi Tada, Akito Nozaki, Makoto Chuma, Shinya Fukunishi, Akira Asai, Toru Asano, Chikara Ogawa, Hiroshi Abe, Naoki Hotta, Toshihide Shima, Etsuko Iio, Shigeru Mikami, Yoshihiko Tachi, Shinichi Fujioka, Hironao Okubo, Noritomo Shimada, Joji Tani, Isao Hidaka, Akio Moriya, Kunihiko Tsuji, Takehiro Akahane, Naoki Yamashita, Tomomi Okubo, Taeang Arai, Kiyoshi Morita, Kazuhito Kawata, Yasuhito Tanaka, Takeshi Okanoue, Shin Maeda, Takashi Kumada, Katsuhiko Iwakiri, KTK49 Liver Study Group

Infect Dis Ther. 2020 Dec; 9(4): 851–866. Published online 2020 Sep 8. doi: 10.1007/s40121-020-00329-y

PMCID:: PMC7680481

Abstract Article PDF–835K

Select item 73255176.

Possible Role of Hepatitis D Virus in Severe Hepatitis Related to Hepatitis B Virus Reactivation After Therapy for Chronic Hepatitis C

Parag Mahale, Jeffrey S. Glenn, Thomas R. O’Brien

Ann Intern Med. Author manuscript; available in PMC 2020 Jun 30.

Published in final edited form as: Ann Intern Med. 2017 Nov 21; 167(10): 759–760. doi: 10.7326/L17-0476

PMCID:: PMC7325517

Article PDF–31K

Select item 70281387.

Ledipasvir‐Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C

Kathleen B. Schwarz, Philip Rosenthal, Karen F. Murray, Jonathan R. Honegger, Winita Hardikar, Rosie Hague, Naveen Mittal, Benedetta Massetto, Diana M. Brainard, Chia‐Hsiang Hsueh, Jiang Shao, Bandita Parhy, Michael R. Narkewicz, Girish S. Rao, Suzanne Whitworth, Sanjay Bansal, William F. Balistreri

Hepatology. 2020 Feb; 71(2): 422–430. Published online 2019 Aug 19. doi: 10.1002/hep.30830

PMCID:: PMC7028138

Abstract Article PDF–159K

Select item 70041038.

Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection

Philip Rosenthal, Kathleen B. Schwarz, Regino P. Gonzalez‐Peralta, Chuan‐Hao Lin, Deidre A. Kelly, Scott Nightingale, William F. Balistreri, Sanjay Bansal, Maureen M. Jonas, Benedetta Massetto, Diana M. Brainard, Chia‐Hsiang Hsueh, Jiang Shao, Bandita Parhy, Suzanne Davison, Cornelia Feiterna‐Sperling, Lynette A. Gillis, Giuseppe Indolfi, Etienne M. Sokal, Karen F. Murray, Stefan Wirth

Hepatology. 2020 Jan; 71(1): 31–43. Published online 2019 Aug 13. doi: 10.1002/hep.30821

PMCID:: PMC7004103

Abstract Article PDF–182K

Select item 66581919.

Sofosbuvir and Simeprevir for Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients

Julio A. Gutierrez, Andres F. Carrion, Danny Avalos, Christopher O’Brien, Paul Martin, Kalyan Ram Bhamidimarri, Adam Peyton

Liver Transpl. Author manuscript; available in PMC 2019 Jul 25.

Published in final edited form as: Liver Transpl. 2015 Jun; 21(6): 823–830. doi: 10.1002/lt.24126

PMCID:: PMC6658191

Abstract Article PDF–94K

Select item 663727810.

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Susanna Naggie, Daniel S Fierer, Michael D Hughes, Arthur Y Kim, Annie Luetkemeyer, Vincent Vu, Jhoanna Roa, Steve Rwema, Diana M Brainard, John G McHutchison, Marion G Peters, Jennifer J Kiser, Kristen M Marks, Raymond T Chung, Acquired Immunodeficiency Syndrome Clinical Trials Group (ACTG) A5327 Study Team

Clin Infect Dis. 2019 Aug 1; 69(3): 514–522. Published online 2019 Mar 28. doi: 10.1093/cid/ciy913

PMCID:: PMC6637278

Abstract Article PDF–962K

Select item 658078111.

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt

Gamal Shiha, Gamal Esmat, Mohamed Hassany, Reham Soliman, Mohamed Elbasiony, Rabab Fouad, Aisha Elsharkawy, Radi Hammad, Wael Abdel-Razek, Talaat Zakareya, Kathryn Kersey, Benedetta Massetto, Anu Osinusi, Sophia Lu, Diana M Brainard, John G McHutchison, Imam Waked, Wahid Doss

Gut. 2019 Apr; 68(4): 721–728. Published online 2018 Apr 17. doi: 10.1136/gutjnl-2017-315906

PMCID:: PMC6580781

Abstract Article PDF–550K

Select item 651981712.

SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

Alessandra Mangia, Valeria Piazzolla, Anna Giannelli, Egidio Visaggi, Nicola Minerva, Vincenzo Palmieri, Immacolata Carraturo, Domenico Potenza, Nicola Napoli, Gianfranco Lauletta, Vincenzo Tagarielli, Rosanna Santoro, Ernesto Piccigallo, Sergio De Gioia, Angelo Chimenti, Giuseppe Cuccorese, Antonio Metrangolo, Michele Mazzola, Ernesto Agostinacchio, Giuseppe Mennea, Carlo Sabbà, Marina Cela, Massimiliano Copetti, Ruggiero Losappio

PLoS One. 2019; 14(5): e0215783. Published online 2019 May 15. doi: 10.1371/journal.pone.0215783

Correction in:: PLoS One. 2019; 14(9): e0223287.

PMCID:: PMC6519817

Abstract Article PDF–750K

Select item 644625913.

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

Anne Laurain, Sophie Metivier, Georges Haour, Dominique Larrey, Céline Dorival, Christophe Hezode, Fabien Zoulim, Patrick Marcellin, Marc Bourliere, Jean-Pierre Zarski, Dominique Thabut, Laurent Alric, Nathalie Ganne-Carrie, Paul Cales, Jean-Pierre Bronowicki, Ghassan Riachi, Claire Geist, Xavier Causse, Armand Abergel, Olivier Chazouilleres, Philippe Mathurin, Dominique Guyader, Didier Samuel, Albert Tran, Véronique Loustaud-Ratti, Ventzislava Petrov-Sanchez, Alpha Diallo, Clovis Luzivika-Nzinga, Hélène Fontaine, Fabrice Carrat, Stanislas Pol, on behalf of the ANRS/AFEF HEPATHER study group

BMC Infect Dis. 2019; 19: 300. Published online 2019 Apr 2. doi: 10.1186/s12879-019-3923-5

PMCID:: PMC6446259

Abstract Article PDF–1.1M

Select item 627689714.

No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection

Mark S. Sulkowski, Wan-Long Chuang, Jia-Horng Kao, Jenny C. Yang, Bing Gao, Diana M. Brainard, Kwang-Hyub Han, Edward Gane

Clin Infect Dis. 2016 Nov 1; 63(9): 1202–1204. Published online 2016 Aug 2. doi: 10.1093/cid/ciw507

PMCID:: PMC6276897

Abstract Article PDF–134K

Select item 624862715.

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

David Wyles, Norbert Bräu, Shyam Kottilil, Eric S Daar, Peter Ruane, Kimberly Workowski, Anne Luetkemeyer, Oluwatoyin Adeyemi, Arthur Y Kim, Brian Doehle, K C Huang, Erik Mogalian, Anu Osinusi, John McNally, Diana M Brainard, John G McHutchison, Susanna Naggie, Mark Sulkowski, for the ASTRAL-5 Investigators

Clin Infect Dis. 2017 Jul 1; 65(1): 6–12. Published online 2017 Mar 29. doi: 10.1093/cid/cix260

PMCID:: PMC6248627

Abstract Article PDF–991K

Select item 607616616.

Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study

Giovanni Battista Gaeta, Alessio Aghemo, Barbara Menzaghi, Gianpiero D’Offizi, Alessia Giorgini, Hamid Hasson, Giuseppina Brancaccio, Maria Palma, Roberta Termini

Medicine (Baltimore) 2018 Jul; 97(27): e11307. Published online 2018 Jul 6. doi: 10.1097/MD.0000000000011307

PMCID:: PMC6076166

Abstract Article PDF–395K

Select item 603899117.

All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response

Noelle Miotto, Leandro Cesar Mendes, Leticia Pisoni Zanaga, Maria Silvia Kroll Lazarini, Eduardo Sellan Lopes Goncales, Marcelo Nardi Pedro, Fernando Lopes Goncales, Jr, Raquel Silveira Bello Stucchi, Aline Gonzalez Vigani

PLoS One. 2018; 13(7): e0199941. Published online 2018 Jul 10. doi: 10.1371/journal.pone.0199941

PMCID:: PMC6038991

Abstract Article PDF–1.2M

Select item 596999118.

Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort

M. Serper, K. A. Forde, D. E. Kaplan

J Viral Hepat. Author manuscript; available in PMC 2019 Feb 1.

Published in final edited form as: J Viral Hepat. 2018 Feb; 25(2): 187–197. Published online 2017 Sep 21. doi: 10.1111/jvh.12784

PMCID:: PMC5969991

Abstract Article PDF–459K

Select item 588019719.

Daclatasvir and sofosbuvir treatment of decompensated liver disease or post‐liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real‐world cohort

Paul Kwo, Michael W. Fried, K. Rajender Reddy, Consuelo Soldevila‐Pico, Saro Khemichian, Jama Darling, Phillippe J. Zamor, Andrew A. Napoli, Beatrice Anduze‐Faris, Robert S. Brown, Jr.

Hepatol Commun. 2018 Apr; 2(4): 354–363. Published online 2018 Feb 27. doi: 10.1002/hep4.1156

PMCID:: PMC5880197

Abstract Article PDF–227K

Select item 575647820.

Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study

Varun Saxena, Vandana Khungar, Elizabeth C. Verna, Josh Levitsky, Robert S. Brown, JR, Mohamed A. Hassan, Mark S. Sulkowski, Jacqueline G. O’Leary, Farrukh Koraishy, Joseph S. Galati, Alexander A. Kuo, Monika Vainorius, Lucy Akushevich, David R. Nelson, Michael W. Fried, Norah Terrault, K.Rajender Reddy

Hepatology. Author manuscript; available in PMC 2018 Oct 1.

Published in final edited form as: Hepatology. 2017 Oct; 66(4): 1090–1101. Published online 2017 Sep 4. doi: 10.1002/hep.29258